LONG-TERM COST-EFFECTIVENESS OF ESKETAMINE FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION

被引：0
|
作者：
Touchette, D. [1 ]
Boyer, N. [2 ]
Atlas, S. J. [3 ]
Agboola, F. O. [4 ]
Talon, B. [1 ]
Schultz, B. [1 ]
Kumar, V. M. [4 ]
Fazioli, K. [4 ]
Fluetsch, N. [4 ]
Rind, D. [4 ]
机构：
[1] Univ Illinois, Coll Pharm, Chicago, IL USA
[2] Univ Chicago Hosp Med, Chicago, IL USA
[3] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA
[4] Inst Clin & Econ Review, Boston, MA USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH16
引用
收藏
页码：S683 / S683
页数：1
相关论文
共 50 条
  • [31] Personalized use of ketamine and esketamine for treatment-resistant depression
    Medeiros, Gustavo C.
    Demo, Isabella
    Goes, Fernando S.
    Zarate Jr, Carlos A.
    Gould, Todd D.
    TRANSLATIONAL PSYCHIATRY, 2024, 14 (01):
  • [32] Esketamine hydrochloride Approved indication: treatment-resistant depression
    不详
    AUSTRALIAN PRESCRIBER, 2022, 45 (01) : 27 - 28
  • [33] Adjunctive Intranasal Esketamine in Treatment-Resistant Depression Reply
    Daly, Ella J.
    Singh, Jaskaran B.
    JAMA PSYCHIATRY, 2018, 75 (06) : 654 - 655
  • [34] Esketamine Nasal Spray (Spravato) for Treatment-Resistant Depression
    Chaplin, Steve
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1569): : 54 - 56
  • [35] Esketamine nasal spray approved for treatment-resistant depression
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (09) : 573 - 573
  • [36] Esketamine Nasal Spray Effective in Treatment-Resistant Depression
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (04): : 296 - 296
  • [37] Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy
    Baldinger-Melich, Pia
    Spies, Marie
    Bozic, Ina
    Kasper, Siegfried
    Rujescu, Dan
    Frey, Richard
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 137 (5) : 134 - 147
  • [38] Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depression
    Cook, John
    Halaris, Angelos
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2022, 119
  • [39] Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review
    Salahudeen, Mohammed S.
    Wright, Cameron M.
    Peterson, Gregory M.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11
  • [40] A REAL-WORLD RETROSPECTIVE STUDY EVALUATING SAFETY, EFFECTIVENESS, AND COST OF INTRANASAL ESKETAMINE FOR TREATMENT-RESISTANT DEPRESSION
    Brendle, M.
    Ahuja, S.
    Valle, M. D.
    Moore, C.
    Thielking, P.
    Malone, D. C.
    Robison, R.
    VALUE IN HEALTH, 2022, 25 (07) : S313 - S313
12345